Inflammatory Bowel Disease and Infection
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (27 January 2022) | Viewed by 4190
Special Issue Editor
Interests: gastroenterology; inflammatory bowel disease; diverticular disease; patient health; endoscopy; CRC screening
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The connection between inflammatory bowel disease (IBD) and infections was established soon after the classification of both Crohn’s disease ( CD) and ulcerative colitis (UC). It is now clear that infections play an important role in pathogenesis, clinical course, and disease exacerbations during IBD. Moreover, the disease itself predisposes patients to various infections, and the infection risk rises even higher during therapy, as the most commonly used medications induce immunomodulation and inhibition. Hence, various drugs have been shown to expose patients to specific infectious agents (e.g., tuberculosis, herpes zoster). Furthermore, immunomodulation affects response to vaccinations, thus further increasing patients’ exposure to infections. As a consequence, national and international guidelines support screening tests, pretreatment vaccinations, and prophylactic therapy for specific cases. Gathering new information on any of these subjects may lead to a better understanding of the mechanism and risk factors and may help in risk stratification and the development of new therapeutic and prophylactic approaches.
Dr. Adi Lahat
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- IBD
- Crohn’s disease
- Ulcerative colitis
- Infections
- Vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
